Verona Pharma

NASDAQ: VRNA · Real-Time Price · USD
105.29
0.02 (0.02%)
At close: Aug 15, 2025, 9:59 AM

Verona Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
42.28M n/a 458K 40M
Cost of Revenue
2.58M 679.62K 346K n/a
Gross Profit
39.7M -679.62K 112K 40M
Operating Income
-154.63M -67.83M -66.12M -73.31M
Interest Income
15.26M 12.81M 2.82M 14K
Pretax Income
-163.13M -55.21M -68.45M -55.59M
Net Income
-173.42M -54.37M -68.7M -55.57M
Selling & General & Admin
149.75M 49.87M 26.58M 33.91M
Research & Development
44.57M 17.28M 49.28M 79.41M
Other Expenses
n/a n/a -9.63M -15.63M
Operating Expenses
194.32M 67.15M 66.23M 97.68M
Interest Expense
23.54M 2.06M 521K 340K
Selling & Marketing Expenses
n/a n/a 19.38M 22.24M
Cost & Expenses
196.91M 67.83M 66.57M 97.68M
Income Tax Expense
10.29M -632.44K 253K -18K
Shares Outstanding (Basic)
81.54M 75.51M 66.06M 59.15M
Shares Outstanding (Diluted)
81.54M 79.27M 66.13M 59.15M
EPS (Basic)
-2.16 -0.72 -1.04 -0.96
EPS (Diluted)
-2.16 -0.69 -1.04 -0.96
EBITDA
-142.19M -52.47M -67.29M -42.19M
EBIT
-139.59M -53.15M -67.93M -55.25M
Depreciation & Amortization
1.06M 679.62K 636K 629K